MedPath

Indocyanine Green Lymphography in Management of Lingual Lymphatic Malformation

Not Applicable
Completed
Conditions
Lymphatic Malformation
Registration Number
NCT06755905
Lead Sponsor
Nanjing Children's Hospital
Brief Summary

To elucidate the application of indocyanine green (ICG) fluorescence angiography in the treatment of childhood tongue cLM (clinically localized malignancy, presumed context here), providing a clearer scientific basis for subsequent targeted interventions.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
42
Inclusion Criteria
  • No previous intervention
  • more than 6 months post-treatment follow-up
  • Stage I or Stage IIa
Exclusion Criteria
  • History of iodine allergy
  • Syndromic cLM
  • Severe liver and kidney dysfunction

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Cured (Reduction in dimension greater than 90%)From enrollment to the end of treatment at 12 weeks

Reduction in dimension greater than 90%

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Children's hospital of nanjing medical university

🇨🇳

Nanjing, Jiangsu, China

© Copyright 2025. All Rights Reserved by MedPath